ChemDiv Extends Partnership with Mondego Bio on PTPN2 Immuno-Oncology Program
ChemDiv has extended its discovery and early development partnership with Mondego Bio to advance a PTPN2-targeting immuno-oncology program, following Mondego's Series A financing led by Biovance Capital.